Exelixis | Należności Handlowe



Trade Debtors Zmiana Data
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
Agios Pharmaceuticals USD 3.34M 765K 2025-03
Amgen USD 8.13B 1.35B 2025-03
AstraZeneca USD 14.82B 16M 2025-03
Bayer EUR 12.5B 1.33B 2024-12
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Cytokinetics USD 16.65M 16.41M 2024-12
Eisai JPY 235.64B 40.42B 2024-12
Eli Lilly USD 14B 727.8M 2025-03
Exelixis USD 265.44M 4.27M 2025-01
Genmab DKK 6.69B 381M 2024-12
Glaxosmithkline GBP 7.32B 542M 2024-12
Incyte USD 823.13M 30.02M 2025-03
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
MacroGenics USD 4.31M 4.44M 2024-12
Merck USD 11.12B 1.06B 2024-12
Moderna USD 306M 286M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Sanofi 10.63B 1.82B 2024-12
Takeda JPY 735.06B 14.01B 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Xencor USD 60.85M 50.64M 2024-12



Exelixis Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.